BIOS Memory SPV I LP 13D and 13G filings for Cognition Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-11-13 5:25 pm Purchase |
2023-11-08 | 13D | Cognition Therapeutics, Inc. CGTX |
BIOS Memory SPV I LP | 6,006,000 19.400% |
491,604 (+8.91%) |
Filing |
| 2022-12-05 5:27 pm Purchase |
2022-11-15 | 13D | Cognition Therapeutics, Inc. CGTX |
BIOS Memory SPV I LP | 5,514,396 23.000% |
1,587,063 (+40.41%) |
Filing |
| 2022-02-01 4:03 pm Purchase |
2022-01-31 | 13D | Cognition Therapeutics, Inc. CGTX |
BIOS Memory SPV I LP | 3,927,333 17.800% |
3,864 (+0.10%) |
Filing |
| 2021-10-25 4:06 pm Purchase |
2021-10-13 | 13D | Cognition Therapeutics, Inc. CGTX |
BIOS Memory SPV I LP | 3,923,469 18.300% |
3,923,469 (New Position) |
Filing |